Notification for Coronary Artery Disease

Phase-Based Progress Estimates
Palo Alto Veteran's Affairs Hospital, Palo Alto, CA
Coronary Artery Disease
Notification - Other
All Sexes
What conditions do you have?

Study Summary

The primary objective is to estimate the impact of notification of primary care provider and patient of at least moderate incidental coronary artery calcification (CAC) on a prior non-gated chest CT on statin prescription rates at 4 months among patients without a clinical history of atherosclerotic cardiovascular disease not actively on statin therapy. This study will determine if notifying patients and their primary care clinician about an existing finding will influence shared decision-making around statins between patients and their primary care clinician.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 4 months

4 months
Statin prescription rate

Trial Safety

Trial Design

2 Treatment Groups

Usual Care
1 of 2
1 of 2
Active Control
Experimental Treatment

600 Total Participants · 2 Treatment Groups

Primary Treatment: Notification · No Placebo Group · N/A

Experimental Group · 1 Intervention: Notification · Intervention Types: Other
Usual CareNoIntervention Group · 1 Intervention: Usual Care · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 4 months
Closest Location: Palo Alto Veteran's Affairs Hospital · Palo Alto, CA
Photo of california 1Photo of california 2Photo of california 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Coronary Artery Disease
0 CompletedClinical Trials

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,130 Previous Clinical Trials
35,668,310 Total Patients Enrolled
18 Trials studying Coronary Artery Disease
15,809 Patients Enrolled for Coronary Artery Disease

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are aged greater than or equal to 18 and less than 85 years.
A CAC score of at least 100 Agatston Units with radiologist confirmation of moderate or severe CAC.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.